1990
DOI: 10.1161/01.cir.82.1.261
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms.

Abstract: Previous studies indicate that exposure of fibrinogen receptors associated with glycoprotein lIb/llla complex contributes to platelet loss during cardiopulmonary bypass. Recently, we isolated a number of RGD (Arg-Gly-Asp)-containing, low molecular weight, cysteine-rich peptides from viper venoms. These peptides, which we propose to call "disintegrins," block platelet-fibrinogen interaction and platelet aggregation. We compared the effect of RGDS (Arg-Gly-Asp-Ser) and four disintegrins (echistatin, flavoridin, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
47
1
2

Year Published

1993
1993
2008
2008

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 130 publications
(53 citation statements)
references
References 32 publications
3
47
1
2
Order By: Relevance
“…RGD peptide, as has been previously reported, has a comparatively low level effect on the inhibition of integrin activity and the prevention of PCO (Nishi et al, 1997a). Indeed, the potency of disintegrins is 500±2000 times higher at inhibiting platelet aggregation (Musial et al, 1990;Jia et al, 1997) and 150±300 times higher at inhibiting retinal pigment epithelial cell attachment to the ECM than the small RGD peptides (Yang et al, 1996). Most of the ECM proteins, such as ®bronectin, laminin, The in¯ammatory conditions of anterior chamber (Hogan et al, 1959) (Nagata and Watanabe, 1996): Grade I (no opaci®cation or limited to less than one quadrant of the posterior capsule periphery), Grade II (opaci®cation extending beyond one quadrant of the periphery but not invading the papillary region).…”
Section: Fig 2 the Inhibition Of Lecsmentioning
confidence: 85%
“…RGD peptide, as has been previously reported, has a comparatively low level effect on the inhibition of integrin activity and the prevention of PCO (Nishi et al, 1997a). Indeed, the potency of disintegrins is 500±2000 times higher at inhibiting platelet aggregation (Musial et al, 1990;Jia et al, 1997) and 150±300 times higher at inhibiting retinal pigment epithelial cell attachment to the ECM than the small RGD peptides (Yang et al, 1996). Most of the ECM proteins, such as ®bronectin, laminin, The in¯ammatory conditions of anterior chamber (Hogan et al, 1959) (Nagata and Watanabe, 1996): Grade I (no opaci®cation or limited to less than one quadrant of the posterior capsule periphery), Grade II (opaci®cation extending beyond one quadrant of the periphery but not invading the papillary region).…”
Section: Fig 2 the Inhibition Of Lecsmentioning
confidence: 85%
“…In contrast to ventral retinal cells, no effect of ephrinB1-Fc was seen on adhesion of dorsal retinal cells. To demonstrate that ephrinB1-stimulated adhesion of ventral retinal cells was mediated by RGD-dependent integrins, adhesion of WT retinal cells to fibronectin was examined in the presence of echistatin, a competitive disintegrin peptide that blocks RGDbinding integrins (Musial et al, 1990). Echistatin significantly reduced basal adhesion of ventral retinal cells and completely abolished the stimulating effect of ephrinB1 on adhesion ( p Ͻ 0.01) (Fig.…”
Section: L1-ankyrin Binding Is Required For Ephrinb1-induced Modulatimentioning
confidence: 93%
“…They are developed from snake venoms and directly influence the b 3 subunit of the integrins, blocking their function. Flavoridin belongs to the snake venom family and potently inhibits blood platelet aggregation [40]. Barbourin, a single disintegrin peptide, contains RGD and KGD.…”
Section: Competitive Peptides and Peptidomimetic Integrin Antagonistsmentioning
confidence: 99%